Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014

Although clinical trials of first- and second-generation tyrosine kinase inhibitors (TKIs) have been shown to improve the prognosis of chronic myeloid leukemia (CML), there is still uncertainty about the clinical features, treatment outcomes, adverse effects, and other possible problems of their use...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hematop
Main Authors: Kawano, Noriaki, Yoshida, Shuro, Kawano, Sayaka, Kuriyama, Takuro, Yamashita, Kiyoshi, Ochiai, Hidenobu, Shimoda, Kazuya, Ishikawa, Fumihiko, Ueda, Akira, Kikuchi, Ikuo
Formato: Artigo
Idioma:Inglês
Publicado em: JSLRT 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144279/
https://ncbi.nlm.nih.gov/pubmed/27334856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.34
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados